cellular macromolecule metabolic process (GO:0044260) | 0.93 | 19 | NSD1, KRAS, KIT, NUP214, CEBPA, RUNX1, GATA2, CBFB, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, PICALM, FLT3, DDX41, TGM6, WHSC1L1 |
cellular process (GO:0009987) | 0.26 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, NSD1, DDX41, FLT3, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, PICALM, RUNX1, TGM6, WHSC1L1 |
cellular metabolic process (GO:0044237) | 0.69 | 19 | NSD1, KRAS, KIT, NUP214, CEBPA, RUNX1, GATA2, CBFB, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, PICALM, FLT3, DDX41, TGM6, WHSC1L1 |
regulation of cellular process (GO:0050794) | 0.5 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, NSD1, DDX41, FLT3, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, PICALM, SH3GL1, RUNX1, GATA2, WHSC1L1 |
organic substance metabolic process (GO:0071704) | 0.63 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, NSD1, DDX41, FLT3, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, PICALM, RUNX1, TGM6, WHSC1L1 |
biological regulation (GO:0065007) | 0.39 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, FLT3, ETV6, JAK2, MLLT10, WHSC1L1, MLF1, TERT, NPM1, PICALM, SH3GL1, RUNX1, DDX41, NSD1 |
metabolic process (GO:0008152) | 0.58 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, RUNX1, GATA2, FLT3, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, PICALM, NSD1, DDX41, TGM6, WHSC1L1 |
macromolecule metabolic process (GO:0043170) | 0.83 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, DDX41, FLT3, ETV6, JAK2, MLLT10, WHSC1L1, MLF1, TERT, NPM1, PICALM, RUNX1, TGM6, NSD1 |
regulation of biological process (GO:0050789) | 0.45 | 19 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, FLT3, ETV6, JAK2, MLLT10, WHSC1L1, MLF1, TERT, NPM1, PICALM, SH3GL1, RUNX1, DDX41, NSD1 |
primary metabolic process (GO:0044238) | 0.69 | 18 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, NSD1, TGM6, FLT3, ETV6, JAK2, MLLT10, MLF1, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 17 | CBFB, KRAS, KIT, NUP214, CEBPA, NSD1, DDX41, FLT3, ETV6, JAK2, MLLT10, NPM1, TERT, PICALM, RUNX1, GATA2, WHSC1L1 |
regulation of metabolic process (GO:0019222) | 1.02 | 17 | CBFB, KRAS, KIT, NUP214, CEBPA, NSD1, GATA2, FLT3, ETV6, MLLT10, JAK2, TERT, NPM1, PICALM, RUNX1, DDX41, WHSC1L1 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 16 | CBFB, KRAS, KIT, FLT3, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 16 | CBFB, KRAS, KIT, FLT3, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
regulation of gene expression (GO:0010468) | 1.37 | 16 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, PICALM, ETV6, JAK2, MLLT10, NSD1, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 15 | CBFB, KRAS, KIT, FLT3, CEBPA, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, NSD1 |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, WHSC1L1 |
regulation of biosynthetic process (GO:0009889) | 1.37 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, WHSC1L1 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 15 | CBFB, KRAS, KIT, FLT3, CEBPA, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, NSD1 |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, WHSC1L1 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 15 | CBFB, KRAS, KIT, FLT3, CEBPA, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, WHSC1L1 |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
single-organism cellular process (GO:0044763) | 0.65 | 15 | CBFB, KRAS, KIT, NUP214, CEBPA, GATA2, FLT3, ETV6, JAK2, MLF1, TERT, NPM1, PICALM, RUNX1, DDX41 |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 15 | CBFB, KRAS, KIT, CEBPA, NSD1, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, WHSC1L1 |
positive regulation of biological process (GO:0048518) | 1.2 | 15 | CBFB, KRAS, KIT, FLT3, CEBPA, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
single-organism process (GO:0044699) | 0.48 | 15 | CBFB, KRAS, KIT, NUP214, CEBPA, DDX41, FLT3, ETV6, JAK2, MLF1, TERT, NPM1, PICALM, RUNX1, GATA2 |
positive regulation of cellular process (GO:0048522) | 1.3 | 15 | CBFB, KRAS, KIT, FLT3, CEBPA, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
developmental process (GO:0032502) | 1.36 | 14 | CBFB, KRAS, KIT, FLT3, CEBPA, GATA2, PICALM, MLF1, JAK2, TERT, NPM1, SH3GL1, RUNX1, DDX41 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 14 | CBFB, KIT, NUP214, CEBPA, NSD1, DDX41, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, GATA2, WHSC1L1 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 13 | CBFB, NUP214, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 13 | CBFB, NUP214, CEBPA, NSD1, DDX41, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, GATA2, WHSC1L1 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 13 | CBFB, NUP214, CEBPA, NSD1, DDX41, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, GATA2, WHSC1L1 |
single-organism developmental process (GO:0044767) | 1.49 | 13 | CBFB, KRAS, KIT, FLT3, CEBPA, GATA2, PICALM, MLF1, JAK2, TERT, NPM1, RUNX1, DDX41 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 13 | CBFB, NUP214, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
positive regulation of gene expression (GO:0010628) | 2.35 | 13 | CBFB, KRAS, KIT, CEBPA, DDX41, PICALM, ETV6, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
negative regulation of biological process (GO:0048519) | 1.33 | 13 | PICALM, KRAS, KIT, NUP214, CEBPA, GATA2, ETV6, JAK2, MLF1, TERT, NPM1, RUNX1, NSD1 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 13 | CBFB, NUP214, CEBPA, NSD1, DDX41, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, GATA2, WHSC1L1 |
heterocycle metabolic process (GO:0046483) | 1.31 | 13 | CBFB, NUP214, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, NPM1, RUNX1, DDX41, WHSC1L1 |
RNA metabolic process (GO:0016070) | 1.59 | 12 | CBFB, NUP214, CEBPA, NSD1, DDX41, ETV6, MLLT10, MLF1, TERT, RUNX1, GATA2, WHSC1L1 |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 12 | CBFB, CEBPA, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
cellular developmental process (GO:0048869) | 1.82 | 12 | CBFB, KRAS, KIT, FLT3, CEBPA, GATA2, ETV6, JAK2, MLF1, TERT, NPM1, RUNX1 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 12 | CBFB, CEBPA, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 12 | CBFB, CEBPA, GATA2, PICALM, ETV6, MLLT10, JAK2, TERT, NPM1, RUNX1, DDX41, NSD1 |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 12 | CBFB, CEBPA, DDX41, PICALM, ETV6, JAK2, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
negative regulation of cellular process (GO:0048523) | 1.41 | 12 | PICALM, KRAS, KIT, CEBPA, GATA2, ETV6, JAK2, MLF1, TERT, NPM1, RUNX1, NSD1 |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 11 | CBFB, CEBPA, DDX41, PICALM, ETV6, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 11 | CBFB, CEBPA, NUP214, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, WHSC1L1 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 11 | CBFB, CEBPA, GATA2, PICALM, ETV6, MLLT10, NPM1, TERT, RUNX1, DDX41, NSD1 |
RNA biosynthetic process (GO:0032774) | 1.84 | 11 | CBFB, NUP214, CEBPA, GATA2, ETV6, MLF1, MLLT10, WHSC1L1, TERT, RUNX1, NSD1 |
anatomical structure development (GO:0048856) | 1.58 | 11 | CBFB, KRAS, KIT, CEBPA, DDX41, MLF1, JAK2, FLT3, SH3GL1, RUNX1, GATA2 |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 11 | CBFB, CEBPA, DDX41, PICALM, ETV6, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 11 | CBFB, CEBPA, DDX41, PICALM, ETV6, MLLT10, NPM1, TERT, RUNX1, GATA2, NSD1 |
cellular biosynthetic process (GO:0044249) | 1.37 | 11 | CBFB, CEBPA, NUP214, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, WHSC1L1 |
biosynthetic process (GO:0009058) | 1.32 | 11 | CBFB, WHSC1L1, NUP214, CEBPA, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, NSD1 |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 11 | CBFB, CEBPA, NUP214, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, WHSC1L1 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 11 | CBFB, CEBPA, GATA2, PICALM, ETV6, MLLT10, NPM1, TERT, RUNX1, DDX41, NSD1 |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 11 | CBFB, NUP214, CEBPA, GATA2, ETV6, MLF1, MLLT10, WHSC1L1, TERT, RUNX1, NSD1 |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 11 | CBFB, NUP214, CEBPA, GATA2, ETV6, MLF1, MLLT10, WHSC1L1, TERT, RUNX1, NSD1 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 11 | CBFB, NUP214, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, WHSC1L1 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 11 | CBFB, WHSC1L1, NUP214, CEBPA, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, NSD1 |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 11 | CBFB, NUP214, CEBPA, GATA2, ETV6, MLF1, MLLT10, WHSC1L1, TERT, RUNX1, NSD1 |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 10 | CBFB, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, WHSC1L1 |
cell differentiation (GO:0030154) | 2.14 | 10 | CBFB, KRAS, KIT, CEBPA, GATA2, ETV6, JAK2, MLF1, FLT3, RUNX1 |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 10 | CBFB, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, TERT, RUNX1, WHSC1L1 |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 10 | PICALM, KRAS, KIT, CEBPA, NUP214, JAK2, WHSC1L1, TERT, NPM1, NSD1 |
cellular component organization (GO:0016043) | 1.24 | 10 | PICALM, KRAS, KIT, CEBPA, NUP214, JAK2, WHSC1L1, TERT, NPM1, NSD1 |
cellular protein metabolic process (GO:0044267) | 1.63 | 9 | CBFB, KRAS, KIT, NUP214, TGM6, JAK2, NSD1, FLT3, WHSC1L1 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 9 | PICALM, KRAS, KIT, CEBPA, GATA2, JAK2, NPM1, FLT3, NSD1 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 9 | PICALM, CEBPA, NUP214, GATA2, ETV6, NPM1, TERT, RUNX1, NSD1 |
regulation of biological quality (GO:0065008) | 1.68 | 9 | PICALM, KIT, CEBPA, NUP214, GATA2, FLT3, JAK2, KRAS, TERT |
single-multicellular organism process (GO:0044707) | 1.78 | 9 | CBFB, KRAS, KIT, CEBPA, DDX41, MLF1, JAK2, RUNX1, GATA2 |
protein metabolic process (GO:0019538) | 1.45 | 9 | CBFB, KRAS, KIT, NUP214, TGM6, JAK2, NSD1, FLT3, WHSC1L1 |
response to stimulus (GO:0050896) | 1.22 | 9 | KRAS, KIT, FLT3, CEBPA, DDX41, JAK2, NPM1, TERT, GATA2 |
regulation of protein metabolic process (GO:0051246) | 1.93 | 9 | PICALM, KRAS, KIT, CEBPA, GATA2, JAK2, NPM1, FLT3, NSD1 |
cellular protein modification process (GO:0006464) | 1.79 | 9 | CBFB, KRAS, KIT, NUP214, TGM6, JAK2, WHSC1L1, FLT3, NSD1 |
macromolecule modification (GO:0043412) | 1.73 | 9 | CBFB, KRAS, KIT, NUP214, TGM6, JAK2, NSD1, FLT3, WHSC1L1 |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 9 | CBFB, CEBPA, DDX41, ETV6, MLLT10, TERT, RUNX1, GATA2, NSD1 |
transcription, DNA-templated (GO:0006351) | 1.91 | 9 | CBFB, CEBPA, NSD1, GATA2, ETV6, MLLT10, MLF1, RUNX1, WHSC1L1 |
protein modification process (GO:0036211) | 1.79 | 9 | CBFB, KRAS, KIT, NUP214, TGM6, JAK2, NSD1, FLT3, WHSC1L1 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 9 | PICALM, CEBPA, NUP214, GATA2, ETV6, NPM1, TERT, RUNX1, NSD1 |
regulation of molecular function (GO:0065009) | 1.78 | 9 | PICALM, KRAS, KIT, FLT3, CEBPA, JAK2, NPM1, TERT, NSD1 |
establishment of localization (GO:0051234) | 1.48 | 9 | CHIC2, KIT, NUP214, GATA2, PICALM, JAK2, NPM1, TERT, SH3GL1 |
localization (GO:0051179) | 1.4 | 9 | CHIC2, KIT, NUP214, GATA2, PICALM, JAK2, NPM1, TERT, SH3GL1 |
multicellular organismal process (GO:0032501) | 1.45 | 9 | CBFB, KRAS, KIT, CEBPA, DDX41, MLF1, JAK2, RUNX1, GATA2 |
regulation of cell proliferation (GO:0042127) | 2.41 | 8 | KRAS, KIT, FLT3, CEBPA, GATA2, JAK2, NPM1, TERT |
transport (GO:0006810) | 1.51 | 8 | CHIC2, KIT, NUP214, GATA2, PICALM, JAK2, NPM1, SH3GL1 |
regulation of catalytic activity (GO:0050790) | 1.97 | 8 | PICALM, KRAS, KIT, FLT3, CEBPA, JAK2, NPM1, TERT |
regulation of response to stimulus (GO:0048583) | 1.54 | 8 | KRAS, KIT, FLT3, NUP214, GATA2, JAK2, NPM1, TERT |
negative regulation of gene expression (GO:0010629) | 2.48 | 8 | PICALM, CEBPA, NUP214, GATA2, ETV6, TERT, RUNX1, NSD1 |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 8 | CBFB, CEBPA, DDX41, ETV6, MLLT10, TERT, RUNX1, GATA2 |
signal transduction (GO:0007165) | 1.28 | 8 | KRAS, KIT, CEBPA, JAK2, NPM1, FLT3, SH3GL1, RUNX1 |
regulation of protein modification process (GO:0031399) | 2.32 | 8 | KRAS, KIT, CEBPA, GATA2, JAK2, NPM1, FLT3, NSD1 |
response to chemical (GO:0042221) | 1.98 | 8 | KIT, FLT3, CEBPA, GATA2, JAK2, KRAS, TERT, DDX41 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 8 | PICALM, CEBPA, GATA2, ETV6, NPM1, TERT, RUNX1, NSD1 |
regulation of phosphorylation (GO:0042325) | 2.5 | 7 | KRAS, KIT, CEBPA, JAK2, NPM1, FLT3, NSD1 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 7 | KRAS, KIT, CEBPA, JAK2, NPM1, FLT3, NSD1 |
cellular response to stimulus (GO:0051716) | 1.97 | 7 | KIT, FLT3, CEBPA, DDX41, JAK2, NPM1, TERT |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 7 | KRAS, KIT, CEBPA, JAK2, NPM1, FLT3, NSD1 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 7 | KRAS, KIT, CEBPA, JAK2, NPM1, FLT3, NSD1 |
positive regulation of molecular function (GO:0044093) | 2.23 | 7 | PICALM, KRAS, KIT, TERT, JAK2, NPM1, FLT3 |
immune system process (GO:0002376) | 2.29 | 7 | CBFB, KIT, GATA2, JAK2, KRAS, FLT3, DDX41 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 7 | KIT, CEBPA, DDX41, JAK2, TERT, RUNX1, GATA2 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 7 | PICALM, KRAS, KIT, CEBPA, JAK2, NPM1, FLT3 |
homeostatic process (GO:0042592) | 2.61 | 7 | PICALM, FLT3, CEBPA, GATA2, JAK2, KRAS, TERT |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 7 | PICALM, KRAS, KIT, CEBPA, JAK2, NPM1, FLT3 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 7 | KIT, CEBPA, DDX41, JAK2, TERT, RUNX1, GATA2 |
regulation of cell death (GO:0010941) | 2.43 | 7 | PICALM, KRAS, KIT, TERT, JAK2, NPM1, FLT3 |
response to organic substance (GO:0010033) | 2.2 | 7 | KIT, CEBPA, GATA2, JAK2, KRAS, FLT3, DDX41 |
positive regulation of cell proliferation (GO:0008284) | 3.01 | 6 | KIT, TERT, KRAS, JAK2, FLT3, NPM1 |
organelle organization (GO:0006996) | 2.02 | 6 | PICALM, KIT, CEBPA, KRAS, NPM1, TERT |
regulation of kinase activity (GO:0043549) | 3.07 | 6 | KIT, CEBPA, KRAS, JAK2, FLT3, NPM1 |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 6 | CEBPA, GATA2, ETV6, TERT, RUNX1, NSD1 |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 6 | PICALM, JAK2, WHSC1L1, TERT, NPM1, NSD1 |
negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 6 | CEBPA, GATA2, ETV6, TERT, RUNX1, NSD1 |
regulation of protein kinase activity (GO:0045859) | 3.15 | 6 | KIT, CEBPA, KRAS, JAK2, FLT3, NPM1 |
regulation of cell differentiation (GO:0045595) | 2.42 | 6 | KIT, CEBPA, GATA2, KRAS, JAK2, RUNX1 |
regulation of transferase activity (GO:0051338) | 2.88 | 6 | KIT, CEBPA, KRAS, JAK2, FLT3, NPM1 |
regulation of signal transduction (GO:0009966) | 1.84 | 6 | KIT, TERT, GATA2, KRAS, JAK2, FLT3 |
regulation of programmed cell death (GO:0043067) | 2.49 | 6 | KIT, TERT, KRAS, JAK2, FLT3, NPM1 |
animal organ development (GO:0048513) | 2.53 | 6 | CBFB, KIT, CEBPA, GATA2, FLT3, RUNX1 |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 6 | KIT, NUP214, JAK2, WHSC1L1, FLT3, NSD1 |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 6 | CEBPA, GATA2, ETV6, TERT, RUNX1, NSD1 |
regulation of signaling (GO:0023051) | 1.72 | 6 | KIT, TERT, GATA2, KRAS, JAK2, FLT3 |
regulation of localization (GO:0032879) | 1.94 | 6 | PICALM, KIT, NUP214, GATA2, JAK2, TERT |
regulation of cell communication (GO:0010646) | 1.73 | 6 | KIT, TERT, GATA2, KRAS, JAK2, FLT3 |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 6 | PICALM, KIT, TERT, KRAS, JAK2, FLT3 |
cellular component assembly (GO:0022607) | 2.14 | 5 | JAK2, PICALM, KIT, TERT, NPM1 |
cytokine-mediated signaling pathway (GO:0019221) | 3.6 | 5 | JAK2, FLT3, KIT, KRAS, CEBPA |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 5 | TERT, FLT3, KIT, JAK2, KRAS |
regulation of cellular component organization (GO:0051128) | 2.01 | 5 | PICALM, GATA2, KIT, NPM1, NSD1 |
positive regulation of signaling (GO:0023056) | 2.41 | 5 | KRAS, FLT3, KIT, JAK2, TERT |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 5 | DDX41, FLT3, KIT, TERT, CEBPA |
positive regulation of cell communication (GO:0010647) | 2.41 | 5 | KRAS, FLT3, KIT, JAK2, TERT |
regulation of protein serine/threonine kinase activity (GO:0071900) | 3.58 | 5 | KRAS, FLT3, KIT, JAK2, CEBPA |
regulation of apoptotic process (GO:0042981) | 2.5 | 5 | KRAS, FLT3, TERT, JAK2, NPM1 |
single-organism metabolic process (GO:0044710) | 1.63 | 5 | PICALM, KRAS, KIT, JAK2, CEBPA |
positive regulation of signal transduction (GO:0009967) | 2.5 | 5 | JAK2, FLT3, KIT, TERT, KRAS |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 5 | KRAS, FLT3, KIT, JAK2, CEBPA |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
regulation of immune system process (GO:0002682) | 2.5 | 5 | RUNX1, GATA2, KIT, KRAS, JAK2 |
transcription from RNA polymerase II promoter (GO:0006366) | 3.38 | 5 | ETV6, CBFB, RUNX1, GATA2, CEBPA |
hematopoietic or lymphoid organ development (GO:0048534) | 4.49 | 5 | KIT, CBFB, RUNX1, GATA2, FLT3 |
cellular localization (GO:0051641) | 2.32 | 5 | JAK2, GATA2, KIT, NPM1, NUP214 |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 5 | TERT, KIT, KRAS, JAK2, NPM1 |
cell proliferation (GO:0008283) | 3.23 | 5 | RUNX1, PICALM, KIT, ETV6, FLT3 |
negative regulation of cell death (GO:0060548) | 2.95 | 5 | JAK2, KRAS, KIT, TERT, NPM1 |
negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
positive regulation of cell differentiation (GO:0045597) | 3.01 | 5 | KIT, GATA2, RUNX1, CEBPA, JAK2 |
single-organism transport (GO:0044765) | 2.18 | 5 | PICALM, GATA2, KIT, JAK2, NUP214 |
negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
establishment of localization in cell (GO:0051649) | 2.47 | 5 | GATA2, KIT, JAK2, NUP214, NPM1 |
single-organism localization (GO:1902578) | 2.09 | 5 | PICALM, GATA2, KIT, JAK2, NUP214 |
multi-organism process (GO:0051704) | 2.65 | 5 | DDX41, KRAS, CEBPA, NUP214, NPM1 |
negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
vesicle-mediated transport (GO:0016192) | 2.72 | 5 | PICALM, CHIC2, KIT, SH3GL1, GATA2 |
intracellular transport (GO:0046907) | 2.67 | 5 | JAK2, GATA2, KIT, NPM1, NUP214 |
regulation of response to stress (GO:0080134) | 2.53 | 5 | TERT, KRAS, JAK2, NUP214, NPM1 |
response to stress (GO:0006950) | 1.8 | 5 | JAK2, DDX41, KIT, TERT, NPM1 |
myeloid cell differentiation (GO:0030099) | 4.63 | 5 | KIT, CBFB, RUNX1, JAK2, CEBPA |
hemopoiesis (GO:0030097) | 5.07 | 5 | KIT, CBFB, RUNX1, GATA2, FLT3 |
negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 5 | ETV6, GATA2, RUNX1, CEBPA, NSD1 |
positive regulation of kinase activity (GO:0033674) | 3.54 | 4 | KRAS, KIT, FLT3, JAK2 |
regulation of transport (GO:0051049) | 2.24 | 4 | PICALM, GATA2, JAK2, NUP214 |
cell motility (GO:0048870) | 3.02 | 4 | GATA2, KIT, KRAS, JAK2 |
cell development (GO:0048468) | 3.28 | 4 | KIT, GATA2, RUNX1, KRAS |
movement of cell or subcellular component (GO:0006928) | 2.61 | 4 | GATA2, KIT, KRAS, JAK2 |
leukocyte activation (GO:0045321) | 3.76 | 4 | CBFB, KIT, GATA2, FLT3 |
regulation of MAP kinase activity (GO:0043405) | 3.95 | 4 | KRAS, KIT, FLT3, JAK2 |
enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 4 | KRAS, KIT, FLT3, JAK2 |
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 4 | KRAS, KIT, FLT3, JAK2 |
intracellular signal transduction (GO:0035556) | 2.39 | 4 | KRAS, KIT, JAK2, NPM1 |
developmental maturation (GO:0021700) | 4.7 | 4 | PICALM, CBFB, GATA2, CEBPA |
regulation of MAPK cascade (GO:0043408) | 3.22 | 4 | FLT3, KIT, JAK2, KRAS |
interspecies interaction between organisms (GO:0044419) | 3.08 | 4 | DDX41, CEBPA, NUP214, NPM1 |
positive regulation of transferase activity (GO:0051347) | 3.31 | 4 | FLT3, KIT, JAK2, KRAS |
protein complex subunit organization (GO:0071822) | 2.6 | 4 | PICALM, TERT, JAK2, NPM1 |
negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 4 | ETV6, GATA2, CEBPA, NSD1 |
chromatin organization (GO:0006325) | 3.28 | 4 | WHSC1L1, JAK2, NSD1, NPM1 |
response to lipid (GO:0033993) | 3.11 | 4 | GATA2, KRAS, FLT3, JAK2 |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 4 | FLT3, KIT, JAK2, KRAS |
positive regulation of protein kinase activity (GO:0045860) | 3.61 | 4 | FLT3, KIT, JAK2, KRAS |
macromolecular complex assembly (GO:0065003) | 2.55 | 4 | PICALM, TERT, JAK2, NPM1 |
cellular response to organic substance (GO:0071310) | 2.78 | 4 | DDX41, KIT, FLT3, CEBPA |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 4 | KRAS, TERT, JAK2, NPM1 |
negative regulation of molecular function (GO:0044092) | 2.74 | 4 | JAK2, PICALM, CEBPA, NPM1 |
cell migration (GO:0016477) | 3.12 | 4 | GATA2, KIT, KRAS, JAK2 |
negative regulation of cell proliferation (GO:0008285) | 3.26 | 4 | JAK2, GATA2, CEBPA, NPM1 |
protein phosphorylation (GO:0006468) | 2.89 | 4 | FLT3, KIT, JAK2, KRAS |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 4 | FLT3, KIT, JAK2, KRAS |
regulation of developmental process (GO:0050793) | 2.1 | 4 | KIT, GATA2, RUNX1, TERT |
protein complex assembly (GO:0006461) | 2.78 | 4 | PICALM, TERT, JAK2, NPM1 |
phosphorylation (GO:0016310) | 2.63 | 4 | FLT3, KIT, JAK2, KRAS |
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091) | 4.29 | 4 | KRAS, KIT, JAK2, NPM1 |
positive regulation of MAPK cascade (GO:0043410) | 3.57 | 4 | FLT3, KIT, JAK2, KRAS |
cell activation (GO:0001775) | 3.47 | 4 | CBFB, KIT, GATA2, FLT3 |
multi-organism cellular process (GO:0044764) | 3.14 | 4 | DDX41, CEBPA, NUP214, NPM1 |
locomotion (GO:0040011) | 2.91 | 4 | GATA2, KIT, KRAS, JAK2 |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 4 | DDX41, CEBPA, NUP214, NPM1 |
positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 4 | KRAS, KIT, FLT3, JAK2 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 4 | KRAS, KIT, FLT3, JAK2 |
leukocyte differentiation (GO:0002521) | 4.13 | 4 | CBFB, KIT, FLT3, CEBPA |
regulation of hydrolase activity (GO:0051336) | 2.53 | 4 | PICALM, KIT, NPM1, JAK2 |
establishment of protein localization (GO:0045184) | 2.53 | 4 | TERT, JAK2, NUP214, NPM1 |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 4 | FLT3, KIT, JAK2, KRAS |
regulation of sequence-specific DNA binding transcription factor activity (GO:0051090) | 3.83 | 4 | KIT, KRAS, JAK2, NPM1 |
regulation of cell cycle (GO:0051726) | 2.93 | 4 | CEBPA, MLF1, NUP214, NPM1 |
positive regulation of protein modification process (GO:0031401) | 2.7 | 4 | KRAS, KIT, FLT3, JAK2 |
chemical homeostasis (GO:0048878) | 2.97 | 4 | PICALM, GATA2, CEBPA, JAK2 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 4 | FLT3, KIT, JAK2, KRAS |
viral process (GO:0016032) | 3.15 | 4 | DDX41, CEBPA, NUP214, NPM1 |
phosphorus metabolic process (GO:0006793) | 2.15 | 4 | FLT3, KIT, JAK2, KRAS |
single-organism intracellular transport (GO:1902582) | 3.59 | 4 | GATA2, KIT, JAK2, NUP214 |
single-organism cellular localization (GO:1902580) | 3.16 | 4 | GATA2, KIT, JAK2, NUP214 |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 4 | KRAS, KIT, FLT3, JAK2 |
nuclear transport (GO:0051169) | 4.2 | 3 | JAK2, NPM1, NUP214 |
protein localization (GO:0008104) | 2.36 | 3 | JAK2, NPM1, NUP214 |
regulation of binding (GO:0051098) | 4.08 | 3 | JAK2, TERT, NSD1 |
regulation of organelle organization (GO:0033043) | 2.72 | 3 | GATA2, NPM1, NSD1 |
embryonic organ development (GO:0048568) | 4.86 | 3 | GATA2, KIT, CEBPA |
positive regulation of JAK-STAT cascade (GO:0046427) | 5.44 | 3 | KIT, FLT3, JAK2 |
metal ion homeostasis (GO:0055065) | 3.61 | 3 | GATA2, PICALM, JAK2 |
cell maturation (GO:0048469) | 4.98 | 3 | CBFB, GATA2, CEBPA |
peptidyl-tyrosine phosphorylation (GO:0018108) | 4.48 | 3 | KIT, FLT3, JAK2 |
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 5.63 | 3 | KIT, FLT3, JAK2 |
positive regulation of MAP kinase activity (GO:0043406) | 4.39 | 3 | KIT, FLT3, KRAS |
regulation of vasculature development (GO:1901342) | 4.26 | 3 | KIT, GATA2, RUNX1 |
cell cycle process (GO:0022402) | 2.75 | 3 | NUP214, MLF1, NPM1 |
lymphocyte differentiation (GO:0030098) | 4.49 | 3 | CBFB, KIT, FLT3 |
cellular macromolecular complex assembly (GO:0034622) | 3.18 | 3 | PICALM, NPM1, JAK2 |
inorganic ion homeostasis (GO:0098771) | 3.43 | 3 | GATA2, PICALM, JAK2 |
positive regulation of protein serine/threonine kinase activity (GO:0071902) | 4.06 | 3 | KIT, KRAS, FLT3 |
cell death (GO:0008219) | 3.05 | 3 | DDX41, KIT, JAK2 |
programmed cell death (GO:0012501) | 3.1 | 3 | DDX41, KIT, JAK2 |
multicellular organism development (GO:0007275) | 2.54 | 3 | DDX41, CEBPA, MLF1 |
signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 3 | KIT, JAK2, KRAS |
regulation of protein localization (GO:0032880) | 2.88 | 3 | PICALM, JAK2, TERT |
response to endogenous stimulus (GO:0009719) | 2.79 | 3 | KIT, KRAS, FLT3 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 3 | PICALM, NPM1, CEBPA |
positive regulation of vasculature development (GO:1904018) | 4.83 | 3 | KIT, GATA2, RUNX1 |
negative regulation of cell cycle (GO:0045786) | 3.67 | 3 | CEBPA, MLF1, NPM1 |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 3 | PICALM, KIT, JAK2 |
regulation of cytokine production (GO:0001817) | 3.4 | 3 | DDX41, RUNX1, JAK2 |
intracellular protein transport (GO:0006886) | 3.2 | 3 | JAK2, NUP214, NPM1 |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 3 | GATA2, RUNX1, JAK2 |
MAPK cascade (GO:0000165) | 3.91 | 3 | KIT, JAK2, KRAS |
hematopoietic progenitor cell differentiation (GO:0002244) | 5.23 | 3 | KIT, FLT3, MLF1 |
protein autophosphorylation (GO:0046777) | 4.46 | 3 | KIT, FLT3, JAK2 |
positive regulation of STAT cascade (GO:1904894) | 5.44 | 3 | KIT, FLT3, JAK2 |
positive regulation of immune system process (GO:0002684) | 2.96 | 3 | GATA2, RUNX1, KRAS |
response to organic cyclic compound (GO:0014070) | 3.07 | 3 | KRAS, FLT3, CEBPA |
histone modification (GO:0016570) | 3.91 | 3 | WHSC1L1, JAK2, NSD1 |
organic substance transport (GO:0071702) | 2.15 | 3 | JAK2, NPM1, NUP214 |
anatomical structure homeostasis (GO:0060249) | 4.25 | 3 | GATA2, KRAS, TERT |
myeloid progenitor cell differentiation (GO:0002318) | 7.78 | 3 | KIT, FLT3, MLF1 |
macromolecule localization (GO:0033036) | 2.34 | 3 | JAK2, NUP214, NPM1 |
regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 3 | KIT, GATA2, RUNX1 |
ion homeostasis (GO:0050801) | 3.42 | 3 | GATA2, PICALM, JAK2 |
negative regulation of developmental process (GO:0051093) | 3.17 | 3 | GATA2, RUNX1, TERT |
response to cytokine (GO:0034097) | 3.84 | 3 | DDX41, FLT3, JAK2 |
regulation of JAK-STAT cascade (GO:0046425) | 4.78 | 3 | KIT, FLT3, JAK2 |
establishment of protein localization to organelle (GO:0072594) | 3.92 | 3 | JAK2, TERT, NUP214 |
negative regulation of cell differentiation (GO:0045596) | 3.33 | 3 | GATA2, RUNX1, KRAS |
nucleocytoplasmic transport (GO:0006913) | 4.23 | 3 | JAK2, NUP214, NPM1 |
defense response (GO:0006952) | 2.78 | 3 | DDX41, KIT, JAK2 |
reproductive process (GO:0022414) | 2.55 | 3 | GATA2, KIT, CEBPA |
immune effector process (GO:0002252) | 3.58 | 3 | DDX41, KIT, GATA2 |
regulation of immune response (GO:0050776) | 2.98 | 3 | KIT, KRAS, JAK2 |
regulation of proteolysis (GO:0030162) | 3.2 | 3 | PICALM, JAK2, CEBPA |
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068) | 5.59 | 3 | KIT, FLT3, JAK2 |
regulation of STAT cascade (GO:1904892) | 4.78 | 3 | KIT, FLT3, JAK2 |
cation homeostasis (GO:0055080) | 3.46 | 3 | GATA2, PICALM, JAK2 |
regulation of neuron death (GO:1901214) | 4.19 | 3 | PICALM, KRAS, JAK2 |
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066) | 4.79 | 3 | KIT, FLT3, JAK2 |
regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 5.49 | 3 | KIT, FLT3, JAK2 |
response to abiotic stimulus (GO:0009628) | 2.8 | 3 | KIT, TERT, KRAS |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 3 | PICALM, NPM1, CEBPA |
single organism reproductive process (GO:0044702) | 2.73 | 3 | GATA2, KIT, CEBPA |
endocytosis (GO:0006897) | 3.69 | 3 | PICALM, SH3GL1, GATA2 |
homeostasis of number of cells (GO:0048872) | 4.98 | 3 | GATA2, KRAS, FLT3 |
response to external stimulus (GO:0009605) | 2.55 | 3 | DDX41, KIT, JAK2 |
positive regulation of developmental process (GO:0051094) | 2.77 | 3 | KIT, GATA2, RUNX1 |
peptidyl-lysine modification (GO:0018205) | 3.98 | 3 | WHSC1L1, NUP214, NSD1 |
regulation of peptidyl-tyrosine phosphorylation (GO:0050730) | 4.35 | 3 | KIT, FLT3, JAK2 |
regulation of cellular response to stress (GO:0080135) | 3.4 | 3 | TERT, NUP214, NPM1 |
negative regulation of catalytic activity (GO:0043086) | 3.0 | 3 | PICALM, NPM1, CEBPA |
peptidyl-tyrosine modification (GO:0018212) | 4.47 | 3 | KIT, FLT3, JAK2 |
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731) | 4.62 | 3 | KIT, FLT3, JAK2 |
single-organism organelle organization (GO:1902589) | 2.68 | 3 | PICALM, KIT, KRAS |
lymphocyte activation (GO:0046649) | 3.96 | 3 | CBFB, KIT, FLT3 |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | KIT, GATA2, RUNX1 |
cellular response to stress (GO:0033554) | 2.51 | 3 | JAK2, TERT, NPM1 |
response to hormone (GO:0009725) | 3.33 | 3 | KIT, KRAS, FLT3 |
protein transport (GO:0015031) | 2.62 | 3 | JAK2, NUP214, NPM1 |
positive regulation of proteolysis (GO:0045862) | 3.86 | 3 | PICALM, JAK2, CEBPA |
positive regulation of cytokine production (GO:0001819) | 3.82 | 3 | DDX41, RUNX1, JAK2 |
developmental process involved in reproduction (GO:0003006) | 3.36 | 3 | GATA2, KIT, CEBPA |
chromatin modification (GO:0016568) | 4.06 | 3 | WHSC1L1, JAK2, NSD1 |
covalent chromatin modification (GO:0016569) | 3.89 | 3 | WHSC1L1, JAK2, NSD1 |
protein methylation (GO:0006479) | 4.96 | 2 | WHSC1L1, NSD1 |
regulation of chromosome organization (GO:0033044) | 4.11 | 2 | GATA2, NSD1 |
negative regulation of transferase activity (GO:0051348) | 3.87 | 2 | NPM1, CEBPA |
hemostasis (GO:0007599) | 4.5 | 2 | GATA2, JAK2 |
regulation of apoptotic signaling pathway (GO:2001233) | 3.83 | 2 | JAK2, TERT |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 2 | GATA2, TERT |
blood coagulation (GO:0007596) | 4.52 | 2 | GATA2, JAK2 |
learning (GO:0007612) | 4.85 | 2 | KIT, KRAS |
activation of protein kinase activity (GO:0032147) | 4.08 | 2 | KIT, JAK2 |
behavior (GO:0007610) | 3.47 | 2 | KIT, KRAS |
learning or memory (GO:0007611) | 4.33 | 2 | KIT, KRAS |
positive regulation of defense response (GO:0031349) | 3.83 | 2 | KRAS, JAK2 |
ossification (GO:0001503) | 4.86 | 2 | CBFB, RUNX1 |
negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 2 | KRAS, JAK2 |
calcium ion homeostasis (GO:0055074) | 3.97 | 2 | GATA2, JAK2 |
regulation of histone modification (GO:0031056) | 4.85 | 2 | GATA2, NSD1 |
negative regulation of myeloid cell differentiation (GO:0045638) | 5.42 | 2 | GATA2, RUNX1 |
establishment of organelle localization (GO:0051656) | 4.15 | 2 | GATA2, KIT |
tissue homeostasis (GO:0001894) | 4.78 | 2 | GATA2, KRAS |
mitochondrion organization (GO:0007005) | 3.69 | 2 | TERT, CEBPA |
response to external biotic stimulus (GO:0043207) | 3.13 | 2 | DDX41, JAK2 |
cellular macromolecule localization (GO:0070727) | 3.1 | 2 | JAK2, NUP214 |
posttranscriptional regulation of gene expression (GO:0010608) | 3.64 | 2 | NPM1, NUP214 |
cell activation involved in immune response (GO:0002263) | 4.86 | 2 | GATA2, KIT |
protein modification by small protein conjugation or removal (GO:0070647) | 2.95 | 2 | CBFB, NUP214 |
protein modification by small protein conjugation (GO:0032446) | 3.1 | 2 | CBFB, NUP214 |
positive regulation of lipid metabolic process (GO:0045834) | 4.88 | 2 | KIT, FLT3 |
B cell differentiation (GO:0030183) | 5.24 | 2 | KIT, FLT3 |
negative regulation of immune system process (GO:0002683) | 3.85 | 2 | GATA2, RUNX1 |
cellular homeostasis (GO:0019725) | 3.23 | 2 | GATA2, JAK2 |
positive regulation of transport (GO:0051050) | 2.9 | 2 | GATA2, JAK2 |
erythrocyte differentiation (GO:0030218) | 5.88 | 2 | KIT, JAK2 |
response to corticosteroid (GO:0031960) | 4.56 | 2 | KRAS, FLT3 |
protein import into nucleus (GO:0006606) | 5.24 | 2 | JAK2, NUP214 |
positive regulation of hemopoiesis (GO:1903708) | 4.63 | 2 | GATA2, RUNX1 |
regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 6.68 | 2 | KIT, JAK2 |
lymphoid progenitor cell differentiation (GO:0002320) | 7.33 | 2 | KIT, FLT3 |
response to biotic stimulus (GO:0009607) | 3.09 | 2 | DDX41, JAK2 |
regulation of hemopoiesis (GO:1903706) | 4.0 | 2 | GATA2, RUNX1 |
negative regulation of hemopoiesis (GO:1903707) | 4.96 | 2 | GATA2, RUNX1 |
system process (GO:0003008) | 2.3 | 2 | KIT, KRAS |
positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 6.9 | 2 | KIT, JAK2 |
stem cell population maintenance (GO:0019827) | 4.83 | 2 | GATA2, KIT |
negative regulation of phosphorylation (GO:0042326) | 3.7 | 2 | NPM1, CEBPA |
organonitrogen compound metabolic process (GO:1901564) | 2.32 | 2 | KIT, CEBPA |
mast cell activation involved in immune response (GO:0002279) | 7.09 | 2 | GATA2, KIT |
single-organism behavior (GO:0044708) | 3.79 | 2 | KIT, KRAS |
myeloid cell activation involved in immune response (GO:0002275) | 6.07 | 2 | GATA2, KIT |
myeloid leukocyte activation (GO:0002274) | 5.15 | 2 | GATA2, KIT |
positive regulation of cytosolic calcium ion concentration (GO:0007204) | 4.56 | 2 | GATA2, JAK2 |
positive regulation of oxidoreductase activity (GO:0051353) | 5.94 | 2 | KRAS, TERT |
regulation of vesicle-mediated transport (GO:0060627) | 3.63 | 2 | GATA2, PICALM |
regulation of neuron apoptotic process (GO:0043523) | 4.47 | 2 | KRAS, JAK2 |
positive regulation of nitric-oxide synthase activity (GO:0051000) | 6.78 | 2 | KRAS, TERT |
negative regulation of kinase activity (GO:0033673) | 4.22 | 2 | NPM1, CEBPA |
visual behavior (GO:0007632) | 5.82 | 2 | KIT, KRAS |
digestive tract development (GO:0048565) | 5.49 | 2 | GATA2, KIT |
peptidyl-lysine methylation (GO:0018022) | 5.42 | 2 | WHSC1L1, NSD1 |
lysosome localization (GO:0032418) | 6.68 | 2 | GATA2, KIT |
regulation of synaptic plasticity (GO:0048167) | 4.78 | 2 | KIT, KRAS |
regulation of cell migration (GO:0030334) | 3.23 | 2 | KIT, JAK2 |
regulation of long-term neuronal synaptic plasticity (GO:0048169) | 6.55 | 2 | KIT, KRAS |
regulation of neuronal synaptic plasticity (GO:0048168) | 5.84 | 2 | KIT, KRAS |
regulation of myeloid leukocyte differentiation (GO:0002761) | 5.02 | 2 | GATA2, RUNX1 |
regulation of oxidoreductase activity (GO:0051341) | 5.27 | 2 | KRAS, TERT |
negative regulation of myeloid leukocyte differentiation (GO:0002762) | 5.9 | 2 | GATA2, RUNX1 |
immune response-regulating signaling pathway (GO:0002764) | 3.72 | 2 | KIT, KRAS |
immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.96 | 2 | KIT, KRAS |
exocytosis (GO:0006887) | 4.11 | 2 | GATA2, KIT |
regulated exocytosis (GO:0045055) | 4.44 | 2 | GATA2, KIT |
leukocyte activation involved in immune response (GO:0002366) | 4.88 | 2 | GATA2, KIT |
histone methylation (GO:0016571) | 5.3 | 2 | WHSC1L1, NSD1 |
regulation of defense response (GO:0031347) | 3.11 | 2 | KRAS, JAK2 |
methylation (GO:0032259) | 4.06 | 2 | WHSC1L1, NSD1 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | GATA2, KIT |
cellular protein localization (GO:0034613) | 3.11 | 2 | JAK2, NUP214 |
lipid metabolic process (GO:0006629) | 2.68 | 2 | KIT, CEBPA |
positive regulation of lipid kinase activity (GO:0090218) | 6.23 | 2 | KIT, FLT3 |
positive regulation of protein localization to nucleus (GO:1900182) | 4.87 | 2 | JAK2, TERT |
regulation of monooxygenase activity (GO:0032768) | 5.69 | 2 | KRAS, TERT |
tissue development (GO:0009888) | 3.27 | 2 | GATA2, JAK2 |
maintenance of cell number (GO:0098727) | 4.82 | 2 | GATA2, KIT |
associative learning (GO:0008306) | 5.44 | 2 | KIT, KRAS |
macromolecule methylation (GO:0043414) | 4.42 | 2 | WHSC1L1, NSD1 |
somatic stem cell population maintenance (GO:0035019) | 5.52 | 2 | GATA2, KIT |
regulation of phospholipid metabolic process (GO:1903725) | 5.69 | 2 | KIT, FLT3 |
negative regulation of neuron death (GO:1901215) | 4.57 | 2 | KRAS, JAK2 |
gland development (GO:0048732) | 4.15 | 2 | GATA2, CEBPA |
regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 6.02 | 2 | KIT, FLT3 |
regulation of protein localization to nucleus (GO:1900180) | 4.34 | 2 | JAK2, TERT |
secretion (GO:0046903) | 3.38 | 2 | GATA2, KIT |
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 6.29 | 2 | KIT, FLT3 |
negative regulation of signal transduction (GO:0009968) | 2.75 | 2 | GATA2, TERT |
coagulation (GO:0050817) | 4.51 | 2 | GATA2, JAK2 |
cellular response to cytokine stimulus (GO:0071345) | 4.33 | 2 | DDX41, FLT3 |
negative regulation of protein modification process (GO:0031400) | 3.4 | 2 | NPM1, CEBPA |
regulation of protein stability (GO:0031647) | 4.33 | 2 | KRAS, TERT |
cognition (GO:0050890) | 4.2 | 2 | KIT, KRAS |
positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | GATA2, KIT |
protein localization to nucleus (GO:0034504) | 4.9 | 2 | JAK2, NUP214 |
regulation of nervous system development (GO:0051960) | 3.1 | 2 | GATA2, KIT |
regulation of cell motility (GO:2000145) | 3.16 | 2 | KIT, JAK2 |
positive regulation of cell motility (GO:2000147) | 3.74 | 2 | KIT, JAK2 |
regulation of myeloid cell differentiation (GO:0045637) | 4.56 | 2 | GATA2, RUNX1 |
positive regulation of cellular amide metabolic process (GO:0034250) | 5.0 | 2 | PICALM, NPM1 |
positive regulation of monooxygenase activity (GO:0032770) | 6.47 | 2 | KRAS, TERT |
regulation of synapse structure or activity (GO:0050803) | 4.77 | 2 | KIT, KRAS |
response to radiation (GO:0009314) | 3.69 | 2 | KIT, KRAS |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | PICALM, NPM1 |
modulation of synaptic transmission (GO:0050804) | 4.09 | 2 | KIT, KRAS |
regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | JAK2, TERT |
negative regulation of signaling (GO:0023057) | 2.65 | 2 | GATA2, TERT |
response to light stimulus (GO:0009416) | 4.08 | 2 | KIT, KRAS |
negative regulation of cell communication (GO:0010648) | 2.66 | 2 | GATA2, TERT |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | GATA2, KRAS |
regulation of GTPase activity (GO:0043087) | 3.21 | 2 | KIT, JAK2 |
visual learning (GO:0008542) | 5.92 | 2 | KIT, KRAS |
positive regulation of cellular protein localization (GO:1903829) | 3.85 | 2 | JAK2, TERT |
regulation of neurogenesis (GO:0050767) | 3.21 | 2 | GATA2, KIT |
positive regulation of phospholipid metabolic process (GO:1903727) | 5.99 | 2 | KIT, FLT3 |
cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 2 | GATA2, JAK2 |
cellular protein complex assembly (GO:0043623) | 3.9 | 2 | PICALM, JAK2 |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 2 | NPM1, CEBPA |
regeneration (GO:0031099) | 4.7 | 2 | FLT3, JAK2 |
regulation of cell development (GO:0060284) | 3.01 | 2 | GATA2, KIT |
positive regulation of neurogenesis (GO:0050769) | 3.77 | 2 | GATA2, KIT |
homeostasis of number of cells within a tissue (GO:0048873) | 6.33 | 2 | GATA2, KRAS |
histone lysine methylation (GO:0034968) | 5.57 | 2 | WHSC1L1, NSD1 |
biological adhesion (GO:0022610) | 2.81 | 2 | LPP, KIT |
cellular response to endogenous stimulus (GO:0071495) | 3.33 | 2 | KIT, FLT3 |
positive regulation of cell development (GO:0010720) | 3.57 | 2 | GATA2, KIT |
regulation of body fluid levels (GO:0050878) | 3.76 | 2 | GATA2, JAK2 |
single-organism nuclear import (GO:1902593) | 5.24 | 2 | JAK2, NUP214 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 2 | GATA2, JAK2 |
cellular calcium ion homeostasis (GO:0006874) | 4.01 | 2 | GATA2, JAK2 |
protein import (GO:0017038) | 4.85 | 2 | JAK2, NUP214 |
cellular ion homeostasis (GO:0006873) | 3.57 | 2 | GATA2, JAK2 |
regulation of cellular amide metabolic process (GO:0034248) | 3.88 | 2 | PICALM, NPM1 |
regulation of DNA binding (GO:0051101) | 5.21 | 2 | JAK2, NSD1 |
regulation of locomotion (GO:0040012) | 3.12 | 2 | KIT, JAK2 |
mitotic cell cycle process (GO:1903047) | 3.12 | 2 | NPM1, NUP214 |
cellular cation homeostasis (GO:0030003) | 3.6 | 2 | GATA2, JAK2 |
definitive hemopoiesis (GO:0060216) | 6.96 | 2 | CBFB, GATA2 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 2 | GATA2, JAK2 |
embryonic placenta development (GO:0001892) | 6.59 | 2 | GATA2, CEBPA |
regulation of fat cell differentiation (GO:0045598) | 5.04 | 2 | GATA2, CEBPA |
positive regulation of NF-kappaB transcription factor activity (GO:0051092) | 4.85 | 2 | KRAS, NPM1 |
aging (GO:0007568) | 4.16 | 2 | NPM1, TERT |
cell aging (GO:0007569) | 5.54 | 2 | NPM1, TERT |
cellular response to organic cyclic compound (GO:0071407) | 3.93 | 2 | FLT3, CEBPA |
positive regulation of binding (GO:0051099) | 4.88 | 2 | JAK2, TERT |
secretion by cell (GO:0032940) | 3.59 | 2 | GATA2, KIT |
protein localization to organelle (GO:0033365) | 3.57 | 2 | JAK2, NUP214 |
system development (GO:0048731) | 2.92 | 2 | GATA2, SH3GL1 |
stem cell proliferation (GO:0072089) | 6.07 | 2 | RUNX1, ETV6 |
response to steroid hormone (GO:0048545) | 4.24 | 2 | KRAS, FLT3 |
regulation of chromatin organization (GO:1902275) | 4.69 | 2 | GATA2, NSD1 |
response to glucocorticoid (GO:0051384) | 4.63 | 2 | KRAS, FLT3 |
regulation of cellular localization (GO:0060341) | 3.03 | 2 | JAK2, TERT |
cell projection organization (GO:0030030) | 3.14 | 2 | KIT, JAK2 |
B cell activation (GO:0042113) | 4.84 | 2 | KIT, FLT3 |
actin cytoskeleton organization (GO:0030036) | 4.1 | 2 | KIT, KRAS |
protein alkylation (GO:0008213) | 4.96 | 2 | WHSC1L1, NSD1 |
leukocyte migration (GO:0050900) | 4.19 | 2 | KIT, KRAS |
Fc receptor signaling pathway (GO:0038093) | 4.45 | 2 | KIT, KRAS |
positive regulation of cell death (GO:0010942) | 3.32 | 2 | PICALM, JAK2 |
regulation of lipid kinase activity (GO:0043550) | 5.84 | 2 | KIT, FLT3 |
divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 2 | GATA2, JAK2 |
mast cell degranulation (GO:0043303) | 7.09 | 2 | GATA2, KIT |
regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | KIT, NPM1 |
regulation of tyrosine phosphorylation of Stat3 protein (GO:0042516) | 5.94 | 2 | KIT, JAK2 |
positive regulation of tyrosine phosphorylation of Stat3 protein (GO:0042517) | 6.12 | 2 | KIT, JAK2 |
positive regulation of angiogenesis (GO:0045766) | 4.93 | 2 | GATA2, RUNX1 |
myeloid leukocyte differentiation (GO:0002573) | 5.23 | 2 | KIT, CEBPA |
leukocyte proliferation (GO:0070661) | 5.25 | 2 | KIT, FLT3 |
positive regulation of myeloid cell differentiation (GO:0045639) | 5.33 | 2 | GATA2, RUNX1 |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 2 | NPM1, CEBPA |
neurological system process (GO:0050877) | 2.64 | 2 | KIT, KRAS |
regulation of angiogenesis (GO:0045765) | 4.36 | 2 | GATA2, RUNX1 |
neuron development (GO:0048666) | 4.8 | 2 | GATA2, RUNX1 |
positive regulation of cell migration (GO:0030335) | 3.77 | 2 | KIT, JAK2 |
negative regulation of protein kinase activity (GO:0006469) | 4.29 | 2 | NPM1, CEBPA |
regulation of innate immune response (GO:0045088) | 3.86 | 2 | KRAS, JAK2 |
actin filament-based process (GO:0030029) | 3.94 | 2 | KIT, KRAS |
regulation of lipid metabolic process (GO:0019216) | 4.08 | 2 | KIT, FLT3 |
regulation of endopeptidase activity (GO:0052548) | 3.8 | 2 | PICALM, JAK2 |
apoptotic process (GO:0006915) | 3.14 | 2 | DDX41, JAK2 |
nuclear import (GO:0051170) | 5.06 | 2 | JAK2, NUP214 |
regulation of Notch signaling pathway (GO:0008593) | 5.51 | 2 | GATA2, KIT |
cell adhesion (GO:0007155) | 2.82 | 2 | LPP, KIT |
tube development (GO:0035295) | 4.41 | 2 | GATA2, KIT |
positive regulation of peptidase activity (GO:0010952) | 4.7 | 2 | PICALM, JAK2 |
regulation of endocytosis (GO:0030100) | 4.42 | 2 | GATA2, PICALM |
organelle localization (GO:0051640) | 3.94 | 2 | GATA2, KIT |
positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | KIT, JAK2 |
regulation of nitric-oxide synthase activity (GO:0050999) | 5.9 | 2 | KRAS, TERT |
positive regulation of cellular component movement (GO:0051272) | 3.71 | 2 | KIT, JAK2 |
regulation of cellular component movement (GO:0051270) | 3.08 | 2 | KIT, JAK2 |
cytoskeleton organization (GO:0007010) | 3.22 | 2 | KIT, KRAS |
hematopoietic stem cell proliferation (GO:0071425) | 7.16 | 2 | RUNX1, ETV6 |
positive regulation of locomotion (GO:0040017) | 3.71 | 2 | KIT, JAK2 |
regulation of cytosolic calcium ion concentration (GO:0051480) | 4.41 | 2 | GATA2, JAK2 |
cellular response to hormone stimulus (GO:0032870) | 3.99 | 2 | KIT, FLT3 |
negative regulation of leukocyte differentiation (GO:1902106) | 5.3 | 2 | GATA2, RUNX1 |
regulation of leukocyte differentiation (GO:1902105) | 4.26 | 2 | GATA2, RUNX1 |
leukocyte degranulation (GO:0043299) | 6.4 | 2 | GATA2, KIT |
regulation of peptidase activity (GO:0052547) | 3.75 | 2 | PICALM, JAK2 |
DNA metabolic process (GO:0006259) | 3.09 | 2 | NPM1, TERT |
negative regulation of protein phosphorylation (GO:0001933) | 3.79 | 2 | NPM1, CEBPA |
RNA processing (GO:0006396) | 3.01 | 2 | DDX41, TERT |
mast cell activation (GO:0045576) | 6.73 | 2 | GATA2, KIT |